XEROX HOLDINGS CORP (XRX) Fundamental Analysis & Valuation

NASDAQ:XRX • US98421M1062

Current stock price

1.56 USD
-0.1 (-6.02%)
Last:

This XRX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. XRX Profitability Analysis

1.1 Basic Checks

  • In the past year XRX has reported negative net income.
  • In the past year XRX had a positive cash flow from operations.
  • XRX had negative earnings in each of the past 5 years.
  • In the past 5 years XRX always reported a positive cash flow from operatings.
XRX Yearly Net Income VS EBIT VS OCF VS FCFXRX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

1.2 Ratios

  • XRX's Return On Assets of -10.62% is in line compared to the rest of the industry. XRX outperforms 45.95% of its industry peers.
  • With a Return On Equity value of -158.51%, XRX is not doing good in the industry: 64.86% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -10.62%
ROE -158.51%
ROIC N/A
ROA(3y)-8.9%
ROA(5y)-6.63%
ROE(3y)-87.49%
ROE(5y)-56.4%
ROIC(3y)N/A
ROIC(5y)N/A
XRX Yearly ROA, ROE, ROICXRX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

1.3 Margins

  • XRX's Gross Margin of 27.07% is in line compared to the rest of the industry. XRX outperforms 48.65% of its industry peers.
  • XRX's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for XRX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 27.07%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.02%
GM growth 5Y-6.26%
XRX Yearly Profit, Operating, Gross MarginsXRX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. XRX Health Analysis

2.1 Basic Checks

  • XRX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • XRX has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for XRX has been reduced compared to 5 years ago.
  • XRX has a worse debt/assets ratio than last year.
XRX Yearly Shares OutstandingXRX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
XRX Yearly Total Debt VS Total AssetsXRX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • Based on the Altman-Z score of 1.10, we must say that XRX is in the distress zone and has some risk of bankruptcy.
  • XRX has a Altman-Z score (1.10) which is comparable to the rest of the industry.
  • The Debt to FCF ratio of XRX is 31.93, which is on the high side as it means it would take XRX, 31.93 years of fcf income to pay off all of its debts.
  • XRX has a Debt to FCF ratio of 31.93. This is comparable to the rest of the industry: XRX outperforms 54.05% of its industry peers.
  • XRX has a Debt/Equity ratio of 6.10. This is a high value indicating a heavy dependency on external financing.
  • XRX has a Debt to Equity ratio of 6.10. This is in the lower half of the industry: XRX underperforms 67.57% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.1
Debt/FCF 31.93
Altman-Z 1.1
ROIC/WACCN/A
WACC4.21%
XRX Yearly LT Debt VS Equity VS FCFXRX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B

2.3 Liquidity

  • A Current Ratio of 1.12 indicates that XRX should not have too much problems paying its short term obligations.
  • The Current ratio of XRX (1.12) is comparable to the rest of the industry.
  • XRX has a Quick Ratio of 1.12. This is a bad value and indicates that XRX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.80, XRX perfoms like the industry average, outperforming 45.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.12
Quick Ratio 0.8
XRX Yearly Current Assets VS Current LiabilitesXRX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. XRX Growth Analysis

3.1 Past

  • XRX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -162.50%.
  • XRX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.88%.
EPS 1Y (TTM)-162.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-127.78%
Revenue 1Y (TTM)12.88%
Revenue growth 3Y-0.4%
Revenue growth 5Y0%
Sales Q2Q%25.73%

3.2 Future

  • Based on estimates for the next years, XRX will show a very strong growth in Earnings Per Share. The EPS will grow by 55.51% on average per year.
  • XRX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.51% yearly.
EPS Next Y177.55%
EPS Next 2Y98.66%
EPS Next 3Y55.51%
EPS Next 5YN/A
Revenue Next Year6.5%
Revenue Next 2Y2.6%
Revenue Next 3Y1.51%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
XRX Yearly Revenue VS EstimatesXRX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 5B 10B 15B
XRX Yearly EPS VS EstimatesXRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. XRX Valuation Analysis

4.1 Price/Earnings Ratio

  • XRX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • A Price/Forward Earnings ratio of 3.35 indicates a rather cheap valuation of XRX.
  • XRX's Price/Forward Earnings ratio is rather cheap when compared to the industry. XRX is cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of XRX to the average of the S&P500 Index (23.83), we can say XRX is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 3.35
XRX Price Earnings VS Forward Price EarningsXRX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, XRX is valued a bit cheaper than the industry average as 78.38% of the companies are valued more expensively.
  • 100.00% of the companies in the same industry are more expensive than XRX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 1.51
EV/EBITDA 14.9
XRX Per share dataXRX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • XRX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • XRX's earnings are expected to grow with 55.51% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y98.66%
EPS Next 3Y55.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. XRX Dividend Analysis

5.1 Amount

  • XRX has a Yearly Dividend Yield of 3.97%.
  • In the last 3 months the price of XRX has falen by -36.40%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 0.63, XRX pays a better dividend. On top of this XRX pays more dividend than 97.30% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, XRX pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.97%

5.2 History

  • The dividend of XRX decreases each year by -12.86%.
  • XRX has been paying a dividend for at least 10 years, so it has a reliable track record.
  • As XRX did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-12.86%
Div Incr Years0
Div Non Decr Years6
XRX Yearly Dividends per shareXRX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • The earnings of XRX are negative and hence is the payout ratio. XRX will probably not be able to sustain this dividend level.
DP-6.81%
EPS Next 2Y98.66%
EPS Next 3Y55.51%
XRX Yearly Income VS Free CF VS DividendXRX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B -1B

More info and screens

Find the best dividend stocksShow peers with best dividend

XRX Fundamentals: All Metrics, Ratios and Statistics

XEROX HOLDINGS CORP

NASDAQ:XRX (3/16/2026, 1:43:46 PM)

1.56

-0.1 (-6.02%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)01-29
Earnings (Next)04-29
Inst Owners82.68%
Inst Owner Change-22.99%
Ins Owners1.04%
Ins Owner Change-1.54%
Market Cap200.62M
Revenue(TTM)7.02B
Net Income(TTM)-1.04B
Analysts46
Price Target3.23 (107.05%)
Short Float %23.87%
Short Ratio7.83
Dividend
Industry RankSector Rank
Dividend Yield 3.97%
Yearly Dividend0.56
Dividend Growth(5Y)-12.86%
DP-6.81%
Div Incr Years0
Div Non Decr Years6
Ex-Date03-31
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-69.66%
Min EPS beat(2)-199.01%
Max EPS beat(2)59.69%
EPS beat(4)1
Avg EPS beat(4)-282.35%
Min EPS beat(4)-892.08%
Max EPS beat(4)59.69%
EPS beat(8)1
Avg EPS beat(8)-166.17%
EPS beat(12)4
Avg EPS beat(12)-91.07%
EPS beat(16)6
Avg EPS beat(16)-75.19%
Revenue beat(2)0
Avg Revenue beat(2)-4.64%
Min Revenue beat(2)-4.65%
Max Revenue beat(2)-4.62%
Revenue beat(4)1
Avg Revenue beat(4)-3%
Min Revenue beat(4)-4.65%
Max Revenue beat(4)0.96%
Revenue beat(8)2
Avg Revenue beat(8)-2.85%
Revenue beat(12)2
Avg Revenue beat(12)-2.67%
Revenue beat(16)4
Avg Revenue beat(16)-2.06%
PT rev (1m)-17.39%
PT rev (3m)-57.61%
EPS NQ rev (1m)-1.23%
EPS NQ rev (3m)-697.44%
EPS NY rev (1m)-40.48%
EPS NY rev (3m)-61.17%
Revenue NQ rev (1m)-0.23%
Revenue NQ rev (3m)-4.8%
Revenue NY rev (1m)-1.95%
Revenue NY rev (3m)1.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 3.35
P/S 0.03
P/FCF 1.51
P/OCF 0.9
P/B 0.3
P/tB N/A
EV/EBITDA 14.9
EPS(TTM)-0.6
EYN/A
EPS(NY)0.47
Fwd EY29.83%
FCF(TTM)1.03
FCFY66.3%
OCF(TTM)1.74
OCFY111.66%
SpS54.6
BVpS5.12
TBVpS-19.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.62%
ROE -158.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 27.07%
FCFM 1.89%
ROA(3y)-8.9%
ROA(5y)-6.63%
ROE(3y)-87.49%
ROE(5y)-56.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.02%
GM growth 5Y-6.26%
F-Score3
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 6.1
Debt/FCF 31.93
Debt/EBITDA 15.15
Cap/Depr 27.49%
Cap/Sales 1.3%
Interest Coverage N/A
Cash Conversion 84.53%
Profit Quality N/A
Current Ratio 1.12
Quick Ratio 0.8
Altman-Z 1.1
F-Score3
WACC4.21%
ROIC/WACCN/A
Cap/Depr(3y)19.43%
Cap/Depr(5y)20.04%
Cap/Sales(3y)0.85%
Cap/Sales(5y)0.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-162.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-127.78%
EPS Next Y177.55%
EPS Next 2Y98.66%
EPS Next 3Y55.51%
EPS Next 5YN/A
Revenue 1Y (TTM)12.88%
Revenue growth 3Y-0.4%
Revenue growth 5Y0%
Sales Q2Q%25.73%
Revenue Next Year6.5%
Revenue Next 2Y2.6%
Revenue Next 3Y1.51%
Revenue Next 5YN/A
EBIT growth 1Y-141.51%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year99.79%
EBIT Next 3Y38.48%
EBIT Next 5YN/A
FCF growth 1Y-71.52%
FCF growth 3Y9.25%
FCF growth 5Y-22.44%
OCF growth 1Y-56.16%
OCF growth 3Y12.1%
OCF growth 5Y-16.38%

XEROX HOLDINGS CORP / XRX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of XEROX HOLDINGS CORP (XRX) stock?

ChartMill assigns a fundamental rating of 3 / 10 to XRX.


Can you provide the valuation status for XEROX HOLDINGS CORP?

ChartMill assigns a valuation rating of 6 / 10 to XEROX HOLDINGS CORP (XRX). This can be considered as Fairly Valued.


What is the profitability of XRX stock?

XEROX HOLDINGS CORP (XRX) has a profitability rating of 2 / 10.


What is the expected EPS growth for XEROX HOLDINGS CORP (XRX) stock?

The Earnings per Share (EPS) of XEROX HOLDINGS CORP (XRX) is expected to grow by 177.55% in the next year.